Bruker Corporation
54.43USD
-3.9400 (-6.75%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 839 | 823 | 977 | 861 | 797 | 801 | 980 | 864 |
| Cost of Revenue | 423 | 444 | 528 | 481 | 440 | 410 | 486 | 446 |
| Gross Profit | 416 | 380 | 449 | 379 | 358 | 391 | 493 | 419 |
| Operating Income | -65 | 10 | 76 | -52 | 12 | 32 | 72 | 68 |
| Net Income | -52 | 14 | 26 | -60 | 8 | 17 | 14 | 41 |
| EPS (Diluted) | $-0.41 | $0.02 | $0.10 | $-0.41 | $0.05 | $0.11 | $0.09 | $0.27 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)